IRCT20210130050179N2招募中2 期
Evaluation of safety and effectiveness of Eczacin cream made by Pharmed Salamat Sina company in improving mild and moderate atopic dermatitis in adults
Sina pharmed salamat0 个研究点目标入组 19 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 19
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit(—)
- 性别
- All
入选标准
- •Chronic or recurrent eczema with a mild to moderate severity and personal or family history of Atopia or high IgE level
- •Signing the consent form for participation in the study
- •Minimum score of one for the SCORAD (Severity Scoring of Atopic Dermatitis index) scale of redness and itching
排除标准
- •Not to use topical medications for Atopic Dermatitis (except for moisturizer) in the last 2 weeks or systemic medications in the last 4 weeks. Use of steroids or systemic immunosuppressive drugs with any indication.
- •Pregnancy or lactating
- •Severe atopic dermatitis (SCORAD above 12)
研究者
相似试验
招募中
不适用
Efficacy and safety of eszopiclone in the treatment of insomnia complicated with nocturnal awakenings associated with urination.Insomnia complicated with nocturnal awakenings associated with urination.JPRN-UMIN000013808Department of medicine,School of Medicine, Nihon University60
进行中(未招募)
1 期
Clinical Study ProtocolSafety and efficacy of escalating doses of LEO 43204 applied once daily for two consecutive days on full balding scalp in subjects with actinic keratosis(sun spots)Part 1: A phase 1. Dose finding study. Follow-up period: 2-weeks Part 2: A phase 2, randomised, doubled, vehicle-controlled study. Follow up period: 8-weeksMedDRA version: 17.0Level: PTClassification code 10000614Term: Actinic keratosisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersActinic KeratosisEUCTR2014-000037-23-DEEO Pharma A/S220
招募中
2 期
Evaluation of the efficacy and safety of colchicine in the prevention for post-CABG atrial fibrillatioAtrial Fibrillation.Unspecified atrial fibrillationI48.91IRCT20200328046886N6Mazandaran University of Medical Sciences172
已完成
1 期
Evaluation of efficacy and safety of Ebola vaccine iEvac-Z in humaJPRN-jRCTs031190118Koga Michiko30
尚未招募
不适用
Evaluation of the efficacy and safety of Escherichia coli-derived recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusioKCT0005610Seoul National University Bundang Hospital154
